Tagged: Kevin Outterson

FDA and outsourced drug making

The Food and Drug Administration reportedly will propose tougher regulations for pharmaceutical companies that outsource manufacturing of drugs, making them more responsible for the safety and purity of the products made by contractors.  Law Professor Kevin Outterson, an authority on food and drug law and director of the Healthy Law Program, says the changes likely […]

Pfizer’s history of illegal marketing

Bloomberg News reports on the history of Pfizer, the world’s largest drug company, illegally promoting drugs for uses not approved by the FDA – even after being heavily fined for doing so.  Law Professor Kevin Outterson, an expert on drug marketing and director of the BU School of Law’s Health Law Program, says big pharma can […]

Glaxo bets on pandemics

British pharmaceutical giant GlaxoSmithKline PLC has spent more than $3.2 billion over the past five years on research and acquisitions specifically related to an anticipated flu pandemic.  Now comes the payoff as the swine flu sweeps the world.  Law Professor Kevin Outterson, head of the Health Law Program and an authority on drug marketing, said Glaxo […]